THE EFFECT OF OBESITY ON ANTI-XA CONCENTRATIONS IN BARIATRIC PATIENTS

被引：0
|
作者：
Schijns, W. [1 ]
Deenen, M. J. [2 ]
Aarts, E. O. [1 ]
Homan, J. [1 ]
Janssen, I. M. C. [1 ]
Berends, F. J. [1 ]
Kaasjager, K. A. H. [3 ]
机构：
[1] Rijnstate Hosp, Vitalys, Arnhem, Netherlands
[2] Rijnstate Hosp, Clin Pharm, Arnhem, Netherlands
[3] Rijnstate Hosp, Internal Med, Arnhem, Netherlands
来源：
OBESITY SURGERY | 2016年 / 26卷
关键词：
Fraxiparin; Factor Xa; Trombosis;
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
O.129
引用
收藏
页码：S139 / S140
页数：2
相关论文
共 50 条
  • [21] THE ANTI-XA ACTIVITY OF LIPOPROTEINS
    BARROWCLIFFE, TW
    EGGLETON, CA
    [J]. THROMBOSIS AND HAEMOSTASIS, 1981, 46 (01) : 351 - 351
  • [22] Observed Apixaban Anti-Xa Levels in Obese Patients
    Harkness, Weston
    Pipitone, Olivia
    Joss, Jacqueline
    Schiedler, Michael
    Shagavah, Santon
    Moore, Ryan
    Hsing, Jeff
    [J]. ANNALS OF PHARMACOTHERAPY, 2022, 56 (11) : 1215 - 1221
  • [23] The effect of renal impairment and obesity on anti-Xa peak and trough levels in patients receiving therapeutic doses of nadroparin: a comparison with control patients
    L. Mast
    M. Y. M. Peeters
    M. Söhne
    C. M. Hackeng
    C. A. J. Knibbe
    M. P. H. van den Broek
    [J]. European Journal of Clinical Pharmacology, 2023, 79 : 1537 - 1547
  • [24] The effect of renal impairment and obesity on anti-Xa peak and trough levels in patients receiving therapeutic doses of nadroparin: a comparison with control patients
    Mast, L.
    Peeters, M. Y. M.
    Soehne, M.
    Hackeng, C. M.
    Knibbe, C. A. J.
    van den Broek, M. P. H.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 79 (11) : 1537 - 1547
  • [25] Recurrent Thrombi in an Obese Patient With History of Bariatric Surgery Despite Anti-Xa Therapy
    Briggler, Rachel
    Matherne, Emma
    Johnson, Chris
    Boehmer, Kaci
    [J]. JOURNAL OF PHARMACY PRACTICE, 2022, 35 (05) : 811 - 816
  • [26] Evaluation of therapeutic anticoagulation with enoxaparin and associated anti-Xa monitoring in patients with morbid obesity: a case series
    Eli N. Deal
    James M. Hollands
    Jennifer N. Riney
    Lee P. Skrupky
    Jennifer R. Smith
    Richard M. Reichley
    [J]. Journal of Thrombosis and Thrombolysis, 2011, 32 : 188 - 194
  • [27] EVALUATION OF ANTI-XA TARGET ATTAINMENT WITH PROPHYLACTIC ENOXAPARIN DOSING REGIMENS IN OBESITY
    Sabers, Andrew
    Reynolds, Brandon
    Langenhan, Emilie
    [J]. CRITICAL CARE MEDICINE, 2023, 51 (01) : 364 - 364
  • [28] Determination of Anti-Xa Inhibitor Plasma Concentrations Using a Universal Edoxaban Calibrator
    Burger, Annika
    Studt, Jan-Dirk
    Mendez, Adriana
    Alberio, Lorenzo
    Fontana, Pierre
    Wuillemin, Walter A.
    Schmidt, Adrian
    Graf, Lukas
    Gerber, Bernhard
    Bovet, Cedric
    Sauter, Thomas C.
    Binder, Nikolaus B.
    Nagler, Michael
    [J]. DIAGNOSTICS, 2023, 13 (12)
  • [29] Evaluation of therapeutic anticoagulation with enoxaparin and associated anti-Xa monitoring in patients with morbid obesity: a case series
    Deal, Eli N.
    Hollands, James M.
    Riney, Jennifer N.
    Skrupky, Lee P.
    Smith, Jennifer R.
    Reichley, Richard M.
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2011, 32 (02) : 188 - 194
  • [30] Fluctuations of anti-Xa concentrations during maintenance enoxaparin therapy for neonatal thrombosis
    Lulic-Botica, Mirjana
    Rajpurkar, Madhvi
    Sabo, Cindy
    Tutag-Lehr, Victoria
    Natarajan, Girija
    [J]. ACTA PAEDIATRICA, 2012, 101 (04) : E147 - E150
12345